La Jolla Pharmaceutical Co. (LJPC) - NASDAQ
  • bakerbros | Send Message 4 Mar

    $LJPC great LT stock
    Reply
      • Michael Blake Kuritz | Send Message 2 Mar

        $LJPC has experienced an incredible bounce
        Reply
          • Lusitanian Traders | Send Message 21 Sep 2015

            $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1Kqqfqc
            Reply
              • Lusitanian Traders | Send Message 18 Sep 2015

                $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1JeDgPC
                Reply
                  • Lusitanian Traders | Send Message 17 Sep 2015

                    $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1gtWJVH
                    Reply
                      • Lusitanian Traders | Send Message 16 Sep 2015

                        $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1iOtqz0
                        Reply
                          • Lusitanian Traders | Send Message 15 Sep 2015

                            $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1QeJDHZ
                            Reply
                              • Lusitanian Traders | Send Message 11 Sep 2015

                                $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1F14pKw
                                Reply
                                  • Lusitanian Traders | Send Message 10 Sep 2015

                                    $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1EXupXs
                                    Reply
                                      • Lusitanian Traders | Send Message 9 Sep 2015

                                        $LJPC - Technical analysis trends (Pivot Points) http://bit.ly/1NprKZB
                                        Reply
                                          Company Description
                                          La Jolla Pharmaceutical Co. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics intended to significantly improve outcomes in patients with life-threatening diseases. It focuses on three product candidates: GCS-100, LJPC-501 and... More
                                          Sector: Healthcare
                                          Industry: Drug Related Products
                                          Country: United States